Following the recalls, 51 people reported adverse effects to the FDA; these reports were reviewed by the US Centers for Disease Control (CDC), which determined that 28 of them were possibly related to StarLink.[32] The CDC studied the blood of these 28 individuals and concluded there was no evidence the reactions these people experienced were associated with hypersensitivity to the StarLink Bt protein.[33]